Showing results (31-40 of 51) with videos related to
Sort By:
Pageof 6
Plos One|May 3, 2019
Csf1r or Mer inhibition delays liver regeneration via suppression of Kupffer cellsJuan A Santamaria-Barria, Shan Zeng, Jonathan B Greer, et al.Plos One|May 10, 2017
Genome and transcriptome profiling of fibrolamellar hepatocellular carcinoma demonstrates p53 and IGF2BP1 dysregulationEric C Sorenson, Raya Khanin, Zubin M Bamboat, et al.Cancer Research|April 4, 2015
Pharmacological Inhibition of KIT Activates MET Signaling in Gastrointestinal Stromal TumorsNoah A Cohen, Shan Zeng, Adrian M Seifert, et al.The Journal of Experimental Medicine|December 11, 2013
KIT oncogene inhibition drives intratumoral macrophage M2 polarizationMichael J Cavnar, Shan Zeng, Teresa S Kim, et al.The Journal of Surgical Research|October 8, 2023
Weekend Discharge Is Not Associated With Increased Readmission After Hyperthermic Intraperitoneal ChemotherapyIsabella Florissi, Shannon N Radomski, Benjamin Shou, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2014
Increased KIT inhibition enhances therapeutic efficacy in gastrointestinal stromal tumorTeresa S Kim, Michael J Cavnar, Noah A Cohen, et al.JCO Oncology Practice|May 16, 2023
Profile of the Postoperative Care Provided for Patients With Pancreatic and Periampullary Cancers by Family and Unpaid CaregiversZhi Ven Fong, Jonathan Teinor, Theresa P Yeo, et al.Journal of the National Cancer Institute|August 19, 2022
Assessment of Caregivers' Burden When Caring for Patients With Pancreatic and Periampullary CancerZhi Ven Fong, Jonathan Teinor, Theresa P Yeo, et al.Cancer|June 25, 2025
Consensus guideline for the management of gastric cancer with synchronous peritoneal metastasesSamuel D Butensky, Varun V Bansal, David G Su, et al.Annals of Surgical Oncology|June 25, 2025
Consensus Guideline for the Management of Gastric Cancer with Synchronous Peritoneal MetastasesSamuel D Butensky, Varun V Bansal, David G Su, et al.Pageof 6